Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Sleepman who wrote (5901)	3/13/2002 9:23:21 PM
From: Biomaven	Read Replies (2) \| Respond to of 52153

Dan, There's been a fair amount of discussion of GZTC here over the years. I used to own it, but fortunately exited my position in disgust at the way they communicated their "progress," and also what could arguably be characterized as the insider selling by GENZ: Message 14756563 It's a lot cheaper now than when I sold it in the mid-teens, but I think this is still a stock where I'll give someone else the first double or triple. Once they have proof of principle, which for me now means an FDA approved product that they are manufacturing, I'll look again. There are some competing approaches - plants and (chicken) eggs. Rick is an investor in Epicyte, which is a private "plantibody" company. LSBC also is playing in this field: Message 16306224 Here's one of the egg players: origentherapeutics.com Peter